U.S. Markets close in 2 hrs 15 mins

Detailed Research: Economic Perspectives on The J. M. Smucker, West Pharmaceutical Services, Franklin Electric Co., Accenture, LiveXLive Media, and Otter Tail — What Drives Growth in Today's Competitive Landscape

NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of The J. M. Smucker Company (SJM), West Pharmaceutical Services, Inc. (WST), Franklin Electric Co., Inc. (FELE), Accenture PLC (ACN), LiveXLive Media, Inc. (LIVX), and Otter Tail Corporation (OTTR), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

SJM DOWNLOAD: http://MarketSourceResearch.com/register/?so=SJM
WST DOWNLOAD: http://MarketSourceResearch.com/register/?so=WST
FELE DOWNLOAD: http://MarketSourceResearch.com/register/?so=FELE
ACN DOWNLOAD: http://MarketSourceResearch.com/register/?so=ACN
LIVX DOWNLOAD: http://MarketSourceResearch.com/register/?so=LIVX
OTTR DOWNLOAD: http://MarketSourceResearch.com/register/?so=OTTR

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine The J. M. Smucker Company (SJM), West Pharmaceutical Services, Inc. (WST), Franklin Electric Co., Inc. (FELE), Accenture PLC (ACN), LiveXLive Media, Inc. (LIVX), and Otter Tail Corporation (OTTR) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed February 19th, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

THE J. M. SMUCKER COMPANY (SJM) REPORT OVERVIEW

The J. M. Smucker's Recent Financial Performance

For the three months ended October 31st, 2018 vs October 31st, 2017, The J. M. Smucker reported revenue of $2,021.50MM vs $1,923.60MM (up 5.09%) and analysts estimated basic earnings per share $1.66 vs $1.71 (down 2.92%). For the twelve months ended April 30th, 2018 vs April 30th, 2017, The J. M. Smucker reported revenue of $7,357.10MM vs $7,392.30MM (down 0.48%) and analysts estimated basic earnings per share $11.79 vs $5.11 (up 130.72%). Analysts expect earnings to be released on February 26th, 2019. The report will be for the fiscal period ending January 31st, 2019. The reported EPS for the same quarter last year was $2.50. The estimated EPS forecast for the next fiscal year is $8.35 and is expected to report on June 6th, 2019.

To read the full The J. M. Smucker Company (SJM) report, download it here: http://MarketSourceResearch.com/register/?so=SJM

-----------------------------------------

WEST PHARMACEUTICAL SERVICES, INC. (WST) REPORT OVERVIEW

West Pharmaceutical Services' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, West Pharmaceutical Services reported revenue of $422.50MM vs $415.60MM (up 1.66%) and analysts estimated basic earnings per share $0.70 vs -$0.01. For the twelve months ended December 31st, 2018 vs December 31st, 2017, West Pharmaceutical Services reported revenue of $1,717.40MM vs $1,599.10MM (up 7.40%) and analysts estimated basic earnings per share $2.80 vs $2.04 (up 37.25%). Analysts expect earnings to be released on April 25th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.62. The estimated EPS forecast for the next fiscal year is $3.31 and is expected to report on February 13th, 2020.

To read the full West Pharmaceutical Services, Inc. (WST) report, download it here: http://MarketSourceResearch.com/register/?so=WST

-----------------------------------------

FRANKLIN ELECTRIC CO., INC. (FELE) REPORT OVERVIEW

Franklin Electric Co.'s Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Franklin Electric Co. reported revenue of $341.87MM vs $311.11MM (up 9.88%) and analysts estimated basic earnings per share $0.64 vs $0.52 (up 23.08%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Franklin Electric Co. reported revenue of $1,124.91MM vs $949.86MM (up 18.43%) and analysts estimated basic earnings per share $1.67 vs $1.67 (unchanged). Analysts expect earnings to be released on May 7th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.45. The estimated EPS forecast for the next fiscal year is $2.65 and is expected to report on February 18th, 2020.

To read the full Franklin Electric Co., Inc. (FELE) report, download it here: http://MarketSourceResearch.com/register/?so=FELE

-----------------------------------------

ACCENTURE PLC (ACN) REPORT OVERVIEW

Accenture's Recent Financial Performance

For the three months ended November 30th, 2018 vs November 30th, 2017, Accenture reported revenue of $10,605.55MM vs $9,884.31MM (up 7.30%) and basic earnings per share $2.00 vs $1.82 (up 9.89%). For the twelve months ended August 31st, 2018 vs August 31st, 2017, Accenture reported revenue of $41,603.43MM vs $36,765.48MM (up 13.16%) and analysts estimated basic earnings per share $6.46 vs $5.56 (up 16.19%). Analysts expect earnings to be released on March 28th, 2019. The report will be for the fiscal period ending February 28th, 2019. The reported EPS for the same quarter last year was $1.58. The estimated EPS forecast for the next fiscal year is $7.84 and is expected to report on September 26th, 2019.

To read the full Accenture PLC (ACN) report, download it here: http://MarketSourceResearch.com/register/?so=ACN

-----------------------------------------

LIVEXLIVE MEDIA, INC. (LIVX) REPORT OVERVIEW

LiveXLive Media's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, LiveXLive Media reported revenue of $8.96MM vs $0.00MM and analysts estimated basic earnings per share -$0.13 vs -$0.19. For the twelve months ended March 31st, 2018 vs March 31st, 2017, LiveXLive Media reported revenue of $7.20MM vs $0.23MM (up 3,097.78%) and analysts estimated basic earnings per share -$0.59 vs -$0.44. Analysts expect earnings to be released on July 5th, 2019. The report will be for the fiscal period ending March 31st, 2019. The estimated EPS forecast for the next fiscal year is $0.08 and is expected to report on July 5th, 2019.

To read the full LiveXLive Media, Inc. (LIVX) report, download it here: http://MarketSourceResearch.com/register/?so=LIVX

-----------------------------------------

OTTER TAIL CORPORATION (OTTR) REPORT OVERVIEW

Otter Tail's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Otter Tail reported revenue of $227.66MM vs $216.46MM (up 5.18%) and analysts estimated basic earnings per share $0.59 vs $0.45 (up 31.11%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Otter Tail reported revenue of $849.35MM vs $803.54MM (up 5.70%) and analysts estimated basic earnings per share $1.84 vs $1.62 (up 13.58%). Analysts expect earnings to be released on May 6th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.66.

To read the full Otter Tail Corporation (OTTR) report, download it here: http://MarketSourceResearch.com/register/?so=OTTR

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com

© 2019 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.